UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 18 Source: CRO
- €36.9 million turnover
-
€25.8 million
profit - 1 employees
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
- 10 more years available »
Ranking
By Turnover
(€36.9 million)- 755th in Top Companies
- 88th in Health
- 75th in Pharma
By Employees
(1)- 986th in Top Companies
- 94th in Health
- 81st in Pharma
-
- 1
- €36.9 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- Jul 11 AIB to compensate another 1,100 tracker mortgage holders
- Jul 11 New Powerscourt Springs hotel to open in defiance of virus gloom
- Jul 10 Irish tech firm to facilitate cashless tickets for hurling and football
- Jul 10 Dublin Port expects full-year volumes to be back at 2016 levels
- Jul 10 Business ‘will not survive’ on essential-only travel - task force